• Chengchen Zhao#, Naiqian Zhang#, Yalin Zhang#, Nuermaimaiti Tuersunjiang, Shaorong Gao, Wenqiang Liu* and Yong Zhang*: A DNA methylation state transition model reveals the programmed epigenetic heterogeneity in human pre-implantation embryos, Genome biology, 2020,21(1):277.(IF=10.806)
• Zheng X#, N Zhang#, Wu H J, et al. Estimating and accounting for tumor purity in the analysis of DNA methylation data from cancer studies, Genome biology, 2017,18(1): 17.(IF=10.806)
• N Zhang#, HJ Wu#, W Zhang, J Wang, H Wu*, X Zheng*: Predicting tumor purity from methylation microarray data, Bioinformatics, 2015,31(21):3401. (IF=4.531)
• N Zhang#, H Wang#, Y Fang, J Wang*, X Zheng*, XS Liu*: Predicting anticancer drug responses using a duallayer integrated cell line-drug network model, PLoS Computational Biology, 2015, 11(9):e1004498.(IF=4.428)
• Z Dong#, N Zhang#, C Li, H Wang, Y Fang, J Wang and X Zheng: Anticancer drug sensitivity prediction in
cell lines from baseline gene expression through recursive feature selection,2015,15:489. (IF=2.933)
• F Wang, N Zhang, J Wang, H Wu, Zheng X：Tumor purity and differential methylation in cancer epigenomics，Briefings in Functional Genomics， 2016，15(6)：408–419. (IF=3.133)
